CD95 ligand in graft rejection (original) (raw)
- Scientific Correspondence
- Published: 22 February 1996
Nature volume 379, page 682 (1996)Cite this article
- 280 Accesses
- 65 Citations
- Metrics details
Article PDF
References
- Bellgrau, D. et al. Nature 377, 630–632 (1995).
Article ADS CAS Google Scholar - Vaux, D. L. Nature 377, 576–577 (1995).
Article ADS CAS Google Scholar - Kayagaki, N. et al. J. exp. Med 182, 1777–1783 (1995).
Article CAS Google Scholar - Abreu-Martin, M. T. et al. J. Immun. 155, 4147–4154 (1995).
CAS PubMed Google Scholar - Iwai, K. et al. Blood 84, 1201–1208 (1994).
CAS PubMed Google Scholar - Tanaka, M. et al. EMBO J. 14, 1129–1135 (1995).
Article CAS Google Scholar - Sullivan, F. P. et al. Transplantation 44, 465–468 (1987).
Article CAS Google Scholar - Kemp, C. B. et al. Diabetologia 9, 486–491 (1973).
Article CAS Google Scholar - Ogasawara, J. et al. Nature 364, 806–809 (1993).
Article ADS CAS Google Scholar
Author information
Authors and Affiliations
- Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113, Japan
Hideo Yagita, Ken-ichiro Seino, Nobuhiko Kayagaki & Ko Okumura
Authors
- Hideo Yagita
You can also search for this author inPubMed Google Scholar - Ken-ichiro Seino
You can also search for this author inPubMed Google Scholar - Nobuhiko Kayagaki
You can also search for this author inPubMed Google Scholar - Ko Okumura
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Yagita, H., Seino, Ki., Kayagaki, N. et al. CD95 ligand in graft rejection.Nature 379, 682 (1996). https://doi.org/10.1038/379682a0
- Issue Date: 22 February 1996
- DOI: https://doi.org/10.1038/379682a0
This article is cited by
An Update on the Pathogenesis of Skin Damage in Lupus
- Qianwen Li
- Haijing Wu
- Qianjin Lu
Current Rheumatology Reports (2020)
CD95 and CD95L promote and protect cancer stem cells
- Paolo Ceppi
- Abbas Hadji
- Marcus E. Peter
Nature Communications (2014)
Tumor counterattack: fact or fiction?
- Frederik H. Igney
- Peter H. Krammer
Cancer Immunology, Immunotherapy (2005)
Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS
- EL Regardsoe
- MM McMenamin
- MJA Wood
Gene Therapy (2004)
The role of Fas ligand in immune privilege
- Douglas R. Green
- Thomas A. Ferguson
Nature Reviews Molecular Cell Biology (2001)